Nanjing Hicin Pharmaceutical Co Ltd (300584) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Nanjing Hicin Pharmaceutical Co Ltd (300584) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.15 Million ≈ $-1.05 Million USD) by net assets (CN¥1.07 Billion ≈ $157.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Nanjing Hicin Pharmaceutical Co Ltd (300584) share price today for real-time trading data and today's change.

Nanjing Hicin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Nanjing Hicin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Nanjing Hicin Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Nanjing Hicin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Hicin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 300584 total assets for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Zero One Technology Co Ltd TW:3029	-0.013x
ST Barbara Ltd AU:SBM	-0.031x
Mesa Laboratories Inc NASDAQ:MLAB	0.100x
STL Technology Co Ltd TWO:4931	0.090x
Fundamenta Real Estate AG SW:FREN	0.021x
DBAPPSecurity Co Ltd SHG:688023	0.004x
Anhui Huamao Textile Co Ltd SHE:000850	0.117x
Core Laboratories NV NYSE:CLB	0.014x

Annual Cash Flow Conversion Efficiency for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. Review financial agility of Nanjing Hicin Pharmaceutical Co Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.94 Million	CN¥78.09 Million ≈ $11.43 Million	0.071x	+22.93%
2024-12-31	CN¥1.04 Billion ≈ $151.92 Million	CN¥59.96 Million ≈ $8.77 Million	0.058x	+138.31%
2023-12-31	CN¥987.50 Million ≈ $144.50 Million	CN¥23.93 Million ≈ $3.50 Million	0.024x	+495.88%
2022-12-31	CN¥950.57 Million ≈ $139.10 Million	CN¥-5.82 Million ≈ $-851.55K	-0.006x	-109.69%
2021-12-31	CN¥948.48 Million ≈ $138.79 Million	CN¥59.94 Million ≈ $8.77 Million	0.063x	-41.53%
2020-12-31	CN¥678.97 Million ≈ $99.35 Million	CN¥73.39 Million ≈ $10.74 Million	0.108x	-27.33%
2019-12-31	CN¥653.98 Million ≈ $95.70 Million	CN¥97.28 Million ≈ $14.23 Million	0.149x	+11.91%
2018-12-31	CN¥580.93 Million ≈ $85.01 Million	CN¥77.21 Million ≈ $11.30 Million	0.133x	+47.79%
2017-12-31	CN¥517.68 Million ≈ $75.75 Million	CN¥46.56 Million ≈ $6.81 Million	0.090x	-34.20%
2016-12-31	CN¥276.11 Million ≈ $40.40 Million	CN¥37.74 Million ≈ $5.52 Million	0.137x	-40.39%
2015-12-31	CN¥235.08 Million ≈ $34.40 Million	CN¥53.90 Million ≈ $7.89 Million	0.229x	+88.91%
2014-12-31	CN¥200.15 Million ≈ $29.29 Million	CN¥24.29 Million ≈ $3.55 Million	0.121x	-55.41%
2013-12-31	CN¥165.93 Million ≈ $24.28 Million	CN¥45.16 Million ≈ $6.61 Million	0.272x	-6.87%
2012-12-31	CN¥132.65 Million ≈ $19.41 Million	CN¥38.77 Million ≈ $5.67 Million	0.292x	--

About Nanjing Hicin Pharmaceutical Co Ltd

SHE:300584 China Drug Manufacturers - Specialty & Generic

Market Cap

$577.72 Million

CN¥3.95 Billion CNY

Market Cap Rank

#11563 Global

#3256 in China

Share Price

CN¥32.90

Change (1 day)

-4.64%

52-Week Range

CN¥30.24 - CN¥77.88

All Time High

CN¥83.16